Brown Z A, Benedetti J, Ashley R, Burchett S, Selke S, Berry S, Vontver L A, Corey L
Department of Obstetrics and Gynecology, University of Washington, Seattle 98195.
N Engl J Med. 1991 May 2;324(18):1247-52. doi: 10.1056/NEJM199105023241804.
To define the risk factors associated with neonatal acquisition of herpes simplex virus (HSV) infection, we prospectively obtained HSV cultures from the cervix and external genitalia of 15,923 pregnant women in early labor who were without symptoms or signs of genital HSV infection. Follow-up of the women with positive cultures for HSV and their HSV-exposed infants included serologic tests and serial cultures for HSV.
HSV was isolated from 56 of the women (0.35 percent), 18 of whom (35 percent) had serologic evidence of a recently acquired, subclinical first episode of genital HSV infection, and 34 of whom (65 percent) had reactivation of HSV. Neonatal HSV developed in 6 of 18 infants (33 percent) born to the women with a first episode of genital HSV, and in 1 of 34 infants (3 percent) born to the women with reactivation of HSV (P less than 0.01); neonatal HSV also occurred in three of the infants born to the 15,867 women with negative cultures. Neonatal HSV-2 occurred in 1 of 4 infants born to mothers seronegative at delivery for both HSV-1 and HSV-2, in 4 of 12 infants exposed to HSV-2 whose mothers had only HSV-1 antibodies at delivery, and in none of the infants born to 31 women who were HSV-2-seropositive. An increased risk of neonatal HSV was associated with exposure to viral shedding from the cervix and the use of fetal-scalp electrodes.
Of the asymptomatic women who shed HSV in early labor, about a third have recently acquired genital HSV, and their infants are 10 times more likely to have neonatal HSV than those of women with asymptomatic reactivation of HSV. The presence of maternal antibodies specific to HSV-2 but not HSV-1 appears to reduce the neonatal transmission of HSV-2. Further studies are necessary to determine whether screening and prophylactic treatment are warranted for infants of HSV-2-seronegative mothers who shed HSV-1 or HSV-2 in early labor.
为确定与新生儿获得单纯疱疹病毒(HSV)感染相关的危险因素,我们前瞻性地从15923名临产前无症状或无生殖器HSV感染体征的孕妇的宫颈和外生殖器采集HSV培养物。对HSV培养阳性的妇女及其暴露于HSV的婴儿进行随访,包括血清学检测和HSV系列培养。
56名妇女(0.35%)分离出HSV,其中18名(35%)有近期获得性、亚临床首次生殖器HSV感染的血清学证据,34名(65%)有HSV再激活。18名首次发生生殖器HSV感染的妇女所生的婴儿中有6名(33%)发生新生儿HSV,34名HSV再激活的妇女所生的婴儿中有1名(3%)发生新生儿HSV(P<0.01);15867名培养阴性的妇女所生的婴儿中有3名发生新生儿HSV。分娩时HSV-1和HSV-2血清学均为阴性的母亲所生的4名婴儿中有1名发生新生儿HSV-2,母亲分娩时仅有HSV-1抗体且暴露于HSV-2的12名婴儿中有4名发生新生儿HSV-2,31名HSV-2血清阳性的妇女所生的婴儿均未发生新生儿HSV-2。新生儿HSV风险增加与接触宫颈病毒脱落物和使用胎儿头皮电极有关。
在临产前无症状排毒的妇女中,约三分之一近期获得生殖器HSV,其婴儿发生新生儿HSV的可能性是无症状HSV再激活妇女婴儿的10倍。母亲存在HSV-2而非HSV-1特异性抗体似乎可降低HSV-2的新生儿传播。有必要进一步研究以确定对临产前排毒HSV-1或HSV-2的HSV-2血清阴性母亲的婴儿是否需要进行筛查和预防性治疗。